Julalak Chokpaisarn

Dr. Julalak Chokpaisarn

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PJPavarish Jantorn
Pavarish Jantorn
HHHawaree Heemmamad
Hawaree Heemmamad
TSTanawan Soimala
Tanawan Soimala
SISaowakon Indoung
Saowakon Indoung
JSJongkon Saising
Jongkon Saising
DSDennapa Saeloh Sotthibandhu
Dennapa Saeloh Sotthibandhu
Staphylococcus pseudintermedius is a zoonotic pathogen that can cause life-threatening infections in animals and humans. The study of methicillin-resistant S. pseudintermedius (MRSP) and its ability to produce biofilms is important to select the most suitable treatment. The prevalence and characteristics of S. pseudintermedius isolated from dogs admitted at the Veterinary Teaching Hospital, Prince of Songkla University, Thailand were assessed. Results showed that 28.30% (15/53) of the isolates were MRSP. Amplification of the mecA gene was observed in 93.33% (14/15) MRSP. Methicillin-resistant strains revealed co-resistant patterns against other antibiotics, including chloramphenicol, clindamycin, tetracycline, clarithromycin, ciprofloxacin, and trimethoprim. In this study, all bacterial isolates produced biofilms, while 90.55% of S. pseudintermedius isolates were strong or moderate biofilm producers. Most (45–60%) of the resistant strains were strong biofilm producers, while the correlation between biofilm production and antibiotic resistance was not statistically significant. This is the first study in southern Thailand to investigate the drug-resistant profile of S. pseudintermedius and its ability to form biofilm. The results will contribute to a better understanding of the emergence and prevalence of antimicrobial resistance in S. pseudintermedius.

8 February 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
KMKanchapat Mahaprom
Kanchapat Mahaprom
JCJulalak Chokpaisarn
Julalak Chokpaisarn
NKNongluk Kunworarath
Nongluk Kunworarath
WPWanhuda Paduka
Wanhuda Paduka
SPSathianpong Phoopha
Sathianpong Phoopha
ONOratai Neamsuvan
Oratai Neamsuvan

10 May 2024 in South African Journal of Botany
Verified
Journal Article
Open access
JCJulalak Chokpaisarn
Julalak Chokpaisarn
WPWanhuda Paduka
Wanhuda Paduka
DSDennapa Saeloh Sotthibandhu
Dennapa Saeloh Sotthibandhu
SPSathianpong Phoopha
Sathianpong Phoopha
SLSurasak Limsuwan
Surasak Limsuwan
KCKamonchanok Chaiwong
Kamonchanok Chaiwong

27 July 2025 in ECTI Transactions on Computer and Information Technology (ECTI-CIT)
Verified
Journal Article
Open access
PDF file
KDKasikrit Damkliang
Kasikrit Damkliang
TSTeerawat Sudkhaw
Teerawat Sudkhaw
TYThitinan Yingtawee
Thitinan Yingtawee
NSNasma Saearma
Nasma Saearma
KMKotchakorn Moosigapong
Kotchakorn Moosigapong
ALAnyamanee Ladam
Anyamanee Ladam
Traditional Thai medicine (TTM) is a popular and increasingly accepted treatment option. In TTM, tongue diagnosis is a highly efficient method for assessing overall health, yet its accuracy can vary significantly depending on the practitioner's expertise. In this work, we hypothesize that deep learning-based transfer learning (TL) methods can achieve high accuracy in the Tri-Dhat classification of tongue images, a system that aligns with TTM principles and categorizes the tongue into three types: Vata, Pitta, and Kapha. We propose an approach that uses raw pixel data and artificial intelligence (AI) to support TTM diagnoses. For our analysis, we used a unique dataset of genuine tongue images collected from our university's TTM hospital. To prepare the data, we performed class balancing and data augmentation. We then developed TL techniques with a variety of pretrained deep learning models. For performance comparisons, we utilized two-tailed paired t-tests and single-factor ANOVA. Our experiments showed that the DenseNet121 and Xception models produced the most significant results with cropped image datasets, including both DSLR- and mobile-taken images. Notably, an ensemble of these models yielded the highest average predictions. This ensemble achieved an accuracy of 0.96, a precision of 0.94, an F1 score of 0.96, a sensitivity of 0.96, and a specificity of 0.97. These results were further supported by a p-value of 0.0003 from the ANOVA analysis. We suggest that our methods could be effectively deployed in real-world scenarios to aid TTM practitioners in their diagnoses.

6 February 2024 in Integrative Medicine Research
Verified
Journal Article
Open access
LJLibin Jia
Libin Jia
MBMichelle A. Beidelschies
Michelle A. Beidelschies
JEJoel M. Evans
Joel M. Evans
RNRichard C. Niemtzow
Richard C. Niemtzow
SNSongxuan Zhou Niemtzow
Songxuan Zhou Niemtzow
CMCecilia C. Maramba-Lazarte
Cecilia C. Maramba-Lazarte
This article - Recommendations and Guidelines of Integrative Medicine (IM) for COVID-19 Care - was one of the outcomes from an Asia-Pacific Economic Cooperation (APEC) Project (Integrative Medicine (IM) and COVID -19 Care) during the time between May 2022 and March 2023. With the efforts from care providers, researchers, health policy makers and healthcare administrative leaders among APEC economies, the purpose of this file was to provide comprehensive IM systems for COVID-19 care as recommendations and suggestive guidelines including care methods, tools, procedures, symptom conditions and targets selections, and points need to be considered during care applications. All cited COVID-19 care practices have confirmed their efficacy and usefulness either used alone or combined with conventional medicine. This article provides current useful medical information on IM for COVID-19 care which could benefit APEC economies and world health communities on their healthcare system.

16 July 2022 in International Journal of Life Science and Pharma Research
Verified
Journal Article
Open access
PDF file
TSThaneeka Sakulchit
Thaneeka Sakulchit
JYJantana Yahuafai
Jantana Yahuafai
TSTeerawat Sudkhaw
Teerawat Sudkhaw
KMKotchakorn Moosigapong
Kotchakorn Moosigapong
DSDennapa Saeloh Sotthibandhu
Dennapa Saeloh Sotthibandhu
JCJulalak Chokpaisarn
Julalak Chokpaisarn
Aum-Ma-Rit recipe (R-AMR), a traditional Thai drug, has been recorded for treatment of GI disorders for several decades. It has been clinically applied as a complementary treatment for taking care of colon cancer patients. However, there are no scientific studies to confirm its traditional use. Therefore, this study was aimed to primarily screen biological properties of RAMR on anti-oxidation as well as anticancer against HT-29 human colon cancer. The recipe with and without tamarind as an aqueous adjuvant was extracted using two types of solvents, water and ethanol. Total phenolic and total flavonoid contents of all tested extracts were evaluated. LC-MS/MS was also performed. DPPH, ABTS, FRAP, and ORAC scavenging assays were used to measure an in vitro antioxidant activity and the property of extracts on killing HT-29 human colon cancer cells was investigated using MTT assay. The result revealed that all sample extracts were composed of a huge source of phenolic and flavonoid. RAMR2.2 possessed an intense antioxidant property against DPPH (17.45 ± 0.3 µg/ml), ABTS (4.04 ±0.01 µg/ml), FRAP (6859.26 ± 0.00 µM of FeSO4 equivalent/mg of extract), ORAC (334.06 ± 18.52 µM of trolox equivalent/mg of extract), and also inhibiting lipid peroxidation (88.78 ± 1.11 %). MTT assay revealed that extracts have no cytotoxic effects on HT-29 human colon cancer cells. R-AMR had a strong ability on anti-oxidation even if it had less cytotoxic effects on HT-29. Therefore, the current study exhibited that the recipe may act as a chemopreventive agent for taking care of cancer patients.